Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders

Launched by UNIVERSIDAD REY JUAN CARLOS · Sep 27, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new device called GOCCLES®, which is designed to help detect early signs of oral cancer in patients who have oral potentially malignant disorders (OPMDs). OPMDs are conditions in the mouth that can sometimes develop into cancer, but traditional methods of diagnosis mainly rely on visual checks, which can vary in accuracy. The GOCCLES® device uses a special light to identify changes in the mouth that may indicate cancer, and the researchers believe it could improve early diagnosis.

To join this study, participants need to be over 18 years old and have specific injuries in their mouth that are associated with OPMDs. It's important for them to understand the study and agree to participate. Those who cannot give consent, have certain health issues that would prevent a biopsy, or have had a recent biopsy in the mouth are not eligible. Participants in this trial can expect to have their oral health assessed using the GOCCLES® device, which may help doctors detect potential issues earlier than with standard methods.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 18.
• • Patients that present oral mucosa injuries compatible with OPMD.
• • Patients that understand the purpose of the study and express consent
• Exclusion Criteria:
• • Patients that don't have the capability to express consent.
• • Patients with systemic pathologies that contraindicate a biopsy.
• • Patients with a recent biopsy at the oral cavity